SCINAI IMMUNOTHERAPEUTICS LT
SCNI · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $1.76
- Today’s Low
- $1.14
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.18
- Previous Close
- $1.16
- Volume
- 43.26K
- Market Cap
- $672.62K
- P/E Ratio
- --
- EPS
- $0.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- JERUSALEM BIOPARK, JERUSALEM, ISRAEL
- Country
- IL
- Listing Date
- 2007-06-07
- Fiscal Year End
- December
- Shares Outstanding
- 20.67B
- CIK
- 0001611747
- Website
- www.scinai.com
Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune disorders. Leveraging its proprietary immune modulation platform, Scinai is advancing a comprehensive clinical pipeline that aims to deliver transformative therapies to enhance patient outcomes. With a seasoned leadership team and a strong commitment to rigorous research, the company is poised to capitalize on the increasing demand for advanced immunotherapeutics in the global healthcare sector. Strategic partnerships further augment Scinai's growth potential, positioning it as a significant contender within the biopharmaceutical industry.
Financial Metrics
Revenue
2026-06-30
$467.89K
2026-03-31
$487.67K
2025-09-30
$269K
2025-06-30
$386.5K
Operating Expenses
2026-06-30
$909.35K
2026-03-31
$1.34M
2025-09-30
$1.19M
2025-06-30
$1.24M
Net Income
2026-06-30
-$2.03M
2026-03-31
$3.56M
2025-09-30
-$2.08M
2025-06-30
-$2.06M
Net Profit Margin
2026-06-30
-435.43%
2026-03-31
731.49%
2025-09-30
-775.65%
2025-06-30
-534.79%
Earnings Per Share
2026-06-30
$-0.74
2026-03-31
$0.94
2025-09-30
$-24.85
2025-06-30
$-2.60
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$1.58M
2026-03-31
-$2M
2025-09-30
-$1.53M
2025-06-30
-$1.52M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-09-30
--
2025-06-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | $467.89K | $487.67K | $269K | $386.5K |
| Operating Expenses | $909.35K | $1.34M | $1.19M | $1.24M |
| Net Income | -$2.03M | $3.56M | -$2.08M | -$2.06M |
| Net Profit Margin | -435.43% | 731.49% | -775.65% | -534.79% |
| Earnings Per Share | $-0.74 | $0.94 | $-24.85 | $-2.60 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$1.58M | -$2M | -$1.53M | -$1.52M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.